Figure 4

![Figure 4: Comparison of drug release profiles from different nanocarrier systems loaded with finasteride or dutasteride. Sustained release kinetics from nanostructured formulations contrast with conventional topical preparations.]()

> Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." *Pharmaceutics*, 2022. PMID: [35214018](https://pubmed.ncbi.nlm.nih.gov/35214018/)

<figure>
  <img src="" alt="Comparison of drug release profiles from different nanocarrier systems loaded with finasteride or dutasteride. Sustained release kinetics from nanostructured formulations contrast with conventional topical preparations." />
  <figcaption>Figure 4. Comparison of drug release profiles from different nanocarrier systems loaded with finasteride or dutasteride. Sustained release kinetics from nanostructured formulations contrast with conventional topical preparations.<br>  Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35214018/">35214018</a></figcaption>
</figure>